Insiders Updates
Taysha Gene Therapies Inc (TSHA) receives a Buy rating from BofA Securities
In a filing, Taysha Gene Therapies Inc revealed its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for
Menu
In a filing, Taysha Gene Therapies Inc revealed its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for
Taysha Gene Therapies Inc’s filing revealed that its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its